Table 3 Ocular, nasal, asthma and overall allergic symptoms using Visual Analogue Scales (VAS) for symptoms and total symptom and medication score (TSMS) (i.e., considering medication use on the respective days)
Active (n: 55) | Control (n: 23) | p-value* | |
|---|---|---|---|
Ocular symptomsa | 1.3 (0.1–8.5) | 4.1 (0.2–10.3) | 0.482 |
Nasal symptomsa | 20.0 (9.2–27.6) | 20.6 (9.0–28.7) | 0.936 |
Asthma symptomsa | 0.4 (0.0–9.5) | 0.1 (0.0–3.0) | 0.503 |
Overall allergic symptomsa | 18.0 (8.7–26.3) | 18.6 (11.6–27.8) | 0.701 |
Ocular TSMSb | 9.5 (6.5–17.4) | 15.7 (12.2–23.6) | 0.019 |
Nasal TSMSb | 18.8 (12.9–22.3) | 23.6 (17.3–28.0) | 0.046 |
Asthma TSMSb | 10.8 (6.6–16.8) | 15.6 (11.1–20.4) | 0.039 |
Overall allergic TSMSb | 17.6 (13.0–22.1) | 23.6 (14.1–28.2) | 0.035 |